Showing Results for
- Academic Journals (5)
Search Results
- 5
Academic Journals
- 5
-
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedSevere acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) virus is the cause of coronavirus disease 2019 (COVID-19). It has caused millions of infections and deaths globally over a 2-year period. Some populations...
-
From:PLoS ONE (Vol. 15, Issue 7) Peer-ReviewedHIV-associated/epidemic Kaposi's sarcoma (EpKS) is an AIDS-defining angio-proliferative malignancy. It can be treated with antiretroviral therapy (ART) alone or with ART plus cytotoxic chemotherapy. ART-treated EpKS can...
-
From:PLoS ONE (Vol. 13, Issue 7) Peer-ReviewedSubtype C HIV-1 is responsible for the largest proportion of people living with HIV-1 infection. However, there is limited information about the roles of the brain and its cell types as a potential sanctuary for this...
-
From:PLoS ONE (Vol. 7, Issue 3) Peer-ReviewedAuthor(s): For Yue Tso 1 , Damien C. Tully 1 , Sandra Gonzalez 1 , Christopher Quince 6 , On Ho 2 , Patricia Polacino 3 , Ruth M. Ruprecht 4 , 5 , Shiu-Lok Hu 2 , 3 , Charles Wood 1 , * Introduction The envelope...
-
From:PLoS ONE (Vol. 16, Issue 3) Peer-ReviewedBackground Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune...